Cannassure Therapeutics Stock Return On Equity
| CSURE Stock | 999.10 49.10 5.17% |
Cannassure Therapeutics fundamentals help investors to digest information that contributes to Cannassure Therapeutics' financial success or failures. It also enables traders to predict the movement of Cannassure Stock. The fundamental analysis module provides a way to measure Cannassure Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannassure Therapeutics stock.
Cannassure |
Cannassure Therapeutics Company Return On Equity Analysis
Cannassure Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Cannassure Therapeutics Return On Equity | -2.11 |
Most of Cannassure Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannassure Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Cannassure Therapeutics has a Return On Equity of -2.1115. This is 91.19% lower than that of the Healthcare sector and significantly lower than that of the Healthcare Providers & Services industry. The return on equity for all Israel stocks is notably higher than that of the company.
Cannassure Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cannassure Therapeutics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cannassure Therapeutics could also be used in its relative valuation, which is a method of valuing Cannassure Therapeutics by comparing valuation metrics of similar companies.Cannassure Therapeutics is currently under evaluation in return on equity category among its peers.
Cannassure Fundamentals
| Return On Equity | -2.11 | |||
| Return On Asset | -0.52 | |||
| Profit Margin | (1.53) % | |||
| Operating Margin | (1.52) % | |||
| Current Valuation | 56.54 M | |||
| Shares Outstanding | 51.17 M | |||
| Shares Owned By Insiders | 51.49 % | |||
| Shares Owned By Institutions | 1.00 % | |||
| Price To Sales | 0.05 X | |||
| Revenue | 16.32 M | |||
| Gross Profit | (14.17 M) | |||
| EBITDA | (20.64 M) | |||
| Net Income | (28.54 M) | |||
| Book Value Per Share | 0.14 X | |||
| Cash Flow From Operations | (20.82 M) | |||
| Earnings Per Share | (0.31) X | |||
| Number Of Employees | 44 | |||
| Beta | 0.69 | |||
| Market Capitalization | 384.26 K |
About Cannassure Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannassure Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannassure Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannassure Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cannassure Stock Analysis
When running Cannassure Therapeutics' price analysis, check to measure Cannassure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannassure Therapeutics is operating at the current time. Most of Cannassure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cannassure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannassure Therapeutics' price. Additionally, you may evaluate how the addition of Cannassure Therapeutics to your portfolios can decrease your overall portfolio volatility.